Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer

We retrospectively evaluated if personalized Kampo medicine (PKM) could facilitate CTL responses and clinical benefits induced by personalized peptide vaccination (PPV), in which HLA-matched vaccines were selected and administered based on the preexisting host immunity, for advanced esophageal cance...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Evid Based Complement Alternat Med
Egile Nagusiak: Muroya, Daisuke, Yutani, Shigeru, Shichijo, Shigeki, Yamada, Akira, Sakamoto, Shinjiro, Naito, Masayasu, Okuda, Koji, Morita, Michi, Yamaguchi, Rin, Itoh, Kyogo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2016
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040795/
https://ncbi.nlm.nih.gov/pubmed/27703488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5929525
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak